BROWSE·page 362 of 661

Browse EX-10 agreements

7,921 total material contract exhibits.


EXHIBIT 10.1

CHEETAH NET SUPPLY CHAIN SERVICE INC.

SECURITIES PURCHASE AGREEMENT

 

 

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of June 15, 2026, by and between Cheetah Net Supply Chain Service Inc., a Delaware corporation (Nasdaq: CTNT) (the “Company”), and Huan Liu, an individual, solely in his individual capacity and not in his capacity as an officer or director of the Company (the “Purchaser”).

 

WHEREAS, subject to the terms and conditions set forth in this Agreement, the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company, the “Shares”), at a purchase price of $2.00 per Share, for an aggregate purchase price of $ 400,000.

 

WHEREAS, the Purchaser is the Chief Executive Officer, Director and Chairman of the Board of Directors of the Company, and the Board of Directors of the Company, acting through a committee of disinterested directors, has reviewed and approved the transactions contemplated hereby as a related-party transaction.

EX-10.1·8-K·CIK 1951667·ACC 0001104659-26-076373·Filed Jun 22, 2026, 16:08 ET

EX-10.1

Adaptive Biotechnologies Corp

[DEALER]1

[______], 2026

 

To:

Adaptive Biotechnologies Corporation

1165 Eastlake Avenue East

Seattle, Washington 98109

Re: [Base][Additional] Call Option Transaction

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [DEALER] (“Dealer”) andAdaptive Biotechnologies Corporation (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. Each party further agrees that this Confirmation together with the Agreement evidence a complete binding agreement between Counterparty and Dealer as to the subject matter and terms of the Transaction to which this Confirmation relates, and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

EX-10.1·8-K·CIK 1478320·ACC 0001193125-26-277516·Filed Jun 22, 2026, 16:07 ET

EX-10.2

Adaptive Biotechnologies Corp

WAIVER AGREEMENT

This WAIVER AGREEMENT (this “Waiver”) is entered into as of June 15, 2026, by and among Adaptive Biotechnologies Corporation, a Washington corporation (the “Company”), OrbiMed Royalty & Credit Opportunities IV, LP, a Delaware limited partnership, in its capacity as Purchaser Agent and as a Purchaser (in such capacities, “OrbiMed”), and each other Purchaser party hereto (OrbiMed, together with such other Purchasers, the “Waiving Parties”).

RECITALS

A. The Company, OrbiMed (as Purchaser Agent) and the Purchasers are parties to that certain Revenue Interest Purchase Agreement, dated as of September 12, 2022 (as amended, supplemented or otherwise modified from time to time, the “Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Purchase Agreement.

EX-10.2·8-K·CIK 1478320·ACC 0001193125-26-277516·Filed Jun 22, 2026, 16:07 ET

EXHIBIT 10.1

Cohen & Co Inc.

FOURTH AMENDMENT TO THIRD AMENDED AND RESTATED LOAN AGREEMENT

 

This Fourth Amendment to Third Amended and Restated Loan Agreement (this “Amendment”) is made as of June 18, 2026, by and between Cohen & Company Securities, LLC, f/k/a J.V.B. Financial Group, LLC, a Delaware limited liability company (“Broker/Dealer”), and Byline Bank (“Lender”), with reference to the following facts:

 

A.            Pursuant to the terms and conditions of that certain Third Amended and Restated Loan Agreement, dated as of June 9, 2023, as amended by that certain First Amendment to Third Amended and Restated Loan Agreement, dated as of December 22, 2023, and effective as of December 21, 2023, that certain Second Amendment to Third Amended and Restated Loan Agreement, dated June 18, 2024, and that certain Third Amendment to Third Amended and Restated Loan Agreement, dated June 20, 2025, and effective as of June 18, 2025 (the “Loan Agreement”) by and between Broker/Dealer and Lender, Lender agreed to make a revolving loan commitment to Broker/Dealer in the principal amount of Fift

EX-10.1·8-K·CIK 1270436·ACC 0001104659-26-076368·Filed Jun 22, 2026, 16:06 ET

EXHIBIT 10.12

Metals Royalty Co Inc.

SUBSCRIPTION AGREEMENT

 

This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is entered into on _________, 2026, by and between The Metals Royalty Company Inc., a company incorporated under the laws of British Columbia (“TMCR”), and the undersigned subscriber (the “Investor”).

 

WHEREAS, this Subscription Agreement is being entered into in connection with TMCR’s acquisition of an interest in a royalty held by Ironclad Royalties LLC with respect to minerals mined at the DR Grade Iron Ore Pelletization plant and mine located in Nashwauk Minnesota (the “Transaction”) to be entered into concurrently with this Subscription Agreement among TMCR, Ironclad Royalties, LLC, Mesabi Investments (USA) LLC and the other parties thereto (the “Transaction Agreement”);

 

WHEREAS, in connection with the Transaction, TMCR is seeking commitments from interested investors to purchase, upon closing of the Transaction, TMCR’s common shares, without par value (the “Shares”), in a private placement for a purchase price of $13.00 per share (the “Per Share Subscription Price”);

EX-10.12·F-1·CIK 2087398·ACC 0001104659-26-076367·Filed Jun 22, 2026, 16:06 ET

EXHIBIT 10.13

Metals Royalty Co Inc.

Execution Version

 

LOAN AGREEMENT

 

AMONG

 

THE METALS ROYALTY COMPANY INC. as Borrower

 

AND

 

THE GUARANTORS from time to time party hereto

as Guarantors

 

AND

 

AMERICAN LIFE & SECURITY CORP. as Lender

 

MADE AS OF June 1, 2026

 

 

 

 

TABLE OF CONTENTS

 

Article 1 INTERPRETATION

1

1.01

Definitions

1

1.02

Headings

19

1.03

Rules of Construction

19

1.04

Number

20

1.05

Accounting Principles

20

1.06

Accounting Practices

20

1.07

Currency

20

1.08

Paramountcy

20

1.09

Non-Business Days

21

1.10

Statutory and Material Agreement References

21

1.11

Determination by the Borrower

21

1.12

Schedules

21

 

 

 

Article 2 THE LOAN FACILITies

22

2.01

Term Loan Facility

22

2.02

Delayed Draw Term Loan Facility

22

2.03

Use of Proceeds

22

2.04

Advance under the Term Loan Facility

22

2.05

Advance under the DDTL Facility

22

2.06

OID

23

2.07

Irrevocability 

23

EX-10.13·F-1·CIK 2087398·ACC 0001104659-26-076367·Filed Jun 22, 2026, 16:06 ET

EXHIBIT 10.11

Metals Royalty Co Inc.

AMENDING AGREEMENT

 

This Amending Agreement made as of the 1st day of June, 2026 among TMCR USA OPERATIONS INC. (the “Purchaser”), THE METALS ROYALTY COMPANY INC. (the “Purchaser Parent”), IRONCLAD ROYALTIES, LLC (the “Vendor”) and MESABI INVESTMENTS (USA) LLC (“MIUSA”).

 

WHEREAS the Purchaser, the Purchaser Parent, the Vendor and MIUSA entered into a Royalty

 

Purchase Agreement (the “Purchase Agreement”) dated as of May 6, 2026 and the Parties wish to amend the Purchase Agreement.

 

NOW THEREFORE THIS AGREEMENT WITNESSES THAT in consideration of the covenants and agreements contained herein and for other good and valuable consideration, the parties hereto agree as follows:

 

1.            Amendments**.** The Purchase Agreement is hereby amended as follows:

 

a.

Section 1.1(gggg) of the Purchase Agreement is hereby deleted and replaced in its entirety with the following:

EX-10.11·F-1·CIK 2087398·ACC 0001104659-26-076367·Filed Jun 22, 2026, 16:06 ET

EX-10.3

STAAR SURGICAL CO

AMENDMENT NO. 2 TO THE

STAAR SURGICAL COMPANY

AMENDED AND RESTATED OMNIBUS EQUITY INCENTIVE PLAN

This Amendment No. 2 (the “Amendment No. 2”) to the STAAR Surgical Company Amended and Restated Omnibus Equity Incentive Plan (the “Plan”) is adopted by the Board of Directors (“Board”) of STAAR Surgical Company, a Delaware corporation (the “Company”) on April 15, 2026. This Amendment No. 2 will become effective upon approval by the Company’s shareholders at the Company’s 2026 annual meeting of shareholders.

WHEREAS, the Plan was last approved by the Company’s shareholders on June 15, 2023; and

WHEREAS, the shareholders approved Amendment No. 1 to the Plan on June 20, 2024; and

WHEREAS, the Board desires to further amend the Plan pursuant to this Amendment No. 2, subject to approval of the Company’s shareholders, to increase the number of shares of Company common stock available for issuance thereunder; and

WHEREAS, if the Company’s shareholders fail to approve this Amendment No. 2, the existing Plan, as amended by Amendment No. 1, shall continue in full force and effect.

EX-10.3·8-K·CIK 718937·ACC 0000718937-26-000029·Filed Jun 22, 2026, 16:05 ET

EX-10.1

Oric Pharmaceuticals, Inc.

ORIC PHARMACEUTICALS, INC.

2020 EQUITY INCENTIVE PLAN

(as amended and restated effective as of June 18, 2026)

 

 

Purposes of the Plan. The purposes of this Plan are:

 

 

 

to attract and retain the best available personnel for positions of substantial responsibility,

 

 

 

to provide additional incentive to Employees, Directors and Consultants, and

 

 

 

to promote the success of the Company’s business.

The Plan permits the grant of Incentive Stock Options, Nonstatutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Units and Performance Shares.

 

 

Definitions. As used herein, the following definitions will apply:

(a) “Administrator” means the Board or any of its Committees as will be administering the Plan, in accordance with Section 4 of the Plan.

EX-10.1·8-K·CIK 1796280·ACC 0001193125-26-277511·Filed Jun 22, 2026, 16:05 ET

EX-10.1

DOMINOS PIZZA INC

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of June 19, 2026 by and between Domino’s Pizza, Inc., a Delaware corporation (the “Company”), and Joseph H. Jordan (the “Executive”), and is effective as of 12:00 a.m. ET on October 1, 2026 (the “Effective Date”).

WHEREAS, the Executive possesses certain experience and expertise that qualifies him to provide the direction and leadership required by the Company; and

WHEREAS, the Company desires to employ the Executive as Chief Executive Officer of the Company and the Executive wishes to accept such employment.

NOW, THEREFORE, in consideration of the mutual covenants contained herein and intending to be legally bound hereby, the Company and the Executive agree as follows:

1. Position and Duties.

EX-10.1·8-K·CIK 1286681·ACC 0001193125-26-277510·Filed Jun 22, 2026, 16:05 ET

EX-10.2

DOMINOS PIZZA INC

June 19, 2026

Mr. Russell J. Weiner

 

Re:

Letter Agreement

Dear Mr. Weiner,

Reference is made to the amended and restated employment agreement by and among you and Domino’s Pizza, Inc., a Delaware corporation (the “Company”), and Domino’s Pizza LLC, a Michigan limited liability company, effective as of May 1, 2022 (the “Employment Agreement”). Capitalized terms not defined in this letter agreement have the meanings given to them in the Employment Agreement. Subject to earlier termination as provided therein, your employment with the Company under the Employment Agreement will continue until 11:59 p.m. ET on September 30, 2026. By entering into this letter agreement with the Company (the “Letter Agreement”), and provided your employment with the Company has not earlier terminated, you agree that your employment with the Company will continue without interruption under the terms and conditions of this Letter Agreement, effective as of 12:00 a.m. ET on October 1, 2026 (the “Effective Date”), as follows:

 

 

EX-10.2·8-K·CIK 1286681·ACC 0001193125-26-277510·Filed Jun 22, 2026, 16:05 ET

ADVANCE SUBSCRIPTION AGREEMENT

 

This Advance Subscription Agreement (this “Agreement”) is entered into as of June 14, 2026, by and between Pluri Inc., a Nevada corporation (the “Company”), and Chutzpah Holdings LP (the “Purchaser”).

 

Advance Payment

 

The Purchaser agrees to pay the Company $1,250,000 (the “Advance Amount”) promptly following the execution of this Agreement, by wire transfer of immediately available funds to the account designated by the Company. The Company will use the Advance Amount for working capital and general corporate purposes.

 

Intended Application to Offering

EX-10.1·8-K·CIK 1158780·ACC 0001213900-26-070609·Filed Jun 22, 2026, 16:01 ET